メリディアンのマラリア検査、権威ある革新賞に輝く
August 31, 2016 09:41 ET
|
Meridian Bioscience, Inc.
シンシナティ, Aug. 31, 2016 (GLOBE NEWSWIRE) -- メリディアン･バイオサイエンス (Meridian Bioscience, Inc.、NASDAQ:VIVO) のマラリア検査、「イルミジーン マラリア (illumigene® Malaria)...
Meridian Malaria Test Wins Prestigious Innovation Award
August 30, 2016 09:46 ET
|
Meridian Bioscience, Inc.
illumigene® Malaria Receives 1st Place Award at theJournées Internationales de Biologie /Association des Colloques Nationaux des Biologistes Conference in Paris CINCINNATI, Aug. 30, 2016 (GLOBE...
Meridian Malaria Test Wins Prestigious Innovation Award
August 25, 2016 13:43 ET
|
Meridian Bioscience, Inc.
illumigene® Malaria Receives 1st Place Award at the Journées Internationales de Biologie /Association des Colloques Nationaux des Biologistes Conference in Paris CINCINNATI, Aug. 25, 2016 ...
Meridian Bioscience Expands Its Portfolio and Launches First Analyte Specific Reagent (ASR) Products
August 23, 2016 09:00 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Aug. 23, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the launch of their Analyte Specific Reagent (ASR) product line. The first ASR products...
Magellan Diagnostics Receives CFDA Clearance for LeadCare® II in China
August 09, 2016 15:00 ET
|
Meridian Bioscience, Inc.
CINCINNATI, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced Magellan Diagnostics, a business unit of Meridian Bioscience, has received clearance from the...
Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance
July 28, 2016 08:00 ET
|
Meridian Bioscience, Inc.
GENERAL HIGHLIGHTS CINCINNATI, July 28, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fiscal 2016 third quarter and first nine months net revenues of $50.7...
Meridian Bioscience, Inc. Receives FDA Clearance for New Molecular Test for the Detection of Mycoplasma pneumoniae
June 15, 2016 08:30 ET
|
Meridian Bioscience, Inc.
CINCINNATI, June 15, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma...
Bioline Launches New MyTaq™ Plant-PCR Kit
June 02, 2016 07:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, June 02, 2016 (GLOBE NEWSWIRE) -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the...
Meridian Bioscience Reports Second Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance
April 28, 2016 07:45 ET
|
Meridian Bioscience Inc.
GENERAL HIGHLIGHTS CINCINNATI, April 28, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., (NASDAQ:VIVO) today: reported fiscal 2016 second quarter and first six months net revenues of $51.3...
Meridian Bioscience bringt neuen Molekulartest fur die Erkennung des Bakteriums Mycoplasma pneumoniae auf den Markt.
April 28, 2016 02:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, April 28, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) gab heute bekannt, dass das Unternehmen die CE-Kennzeichnung für seinen neuen Test zur molekularen...